Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities research analysts at StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on CTIC. Stifel Nicolaus cut CTI BioPharma from […]
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. TD Cowen reduced their target price on shares of CTI BioPharma from $10.00 to $8.00 […]
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the subject of several other research reports. SVB Securities lowered shares of CTI BioPharma from an outperform rating to a […]
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on CTIC. JMP Securities downgraded CTI BioPharma from an outperform rating to a […]